The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Abstract
CONTEXT: Although oligomenorrhea has been associated cross-sectionally with insulin resistance and glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of type 2 diabetes mellitus (DM). OBJECTIVE: To prospectively assess risk of type 2 DM in women with a history of long or highly irregular menstrual cycles. DESIGN AND SETTING: The Nurses' Health Study II, a prospective observational cohort study. PARTICIPANTS: A total of 101 073 women who had no prior history of DM and who reported their usual menstrual cycle pattern at age 18 to 22 years on the baseline (1989) questionnaire. MAIN OUTCOME MEASURE: Incident reports of DM, with follow-up through 1997, compared among women categorized by menstrual cycle length (5 categories). RESULTS: During 564 333 person-years of follow-up, there were 507 cases of type 2 DM. Compared with women with a usual cycle length of 26 to 31 days (referent category) at age 18 to 22 years, the relative risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was too irregular to estimate was 2.08 (95% confidence interval [CI], 1.62-2.66), adjusting for body mass index at age 18 years and several other potential confounding variables. The RR of type 2 DM associated with long or highly irregular menstrual cycles was greater in obese women, but was also increased in nonobese women (at body mass indexes at age 18 years of <25, 25-29, and >/=30 kg/m, RRs were 1.67 [95% CI, 1.14-2.45], 1.74 [95% CI, 1.07-2.82], and 3.86 [95% CI, 2.33-6.38], respectively). CONCLUSION: Women with long or highly irregular menstrual cycles have a significantly increased risk for developing type 2 DM that is not completely explained by obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this reason, PCOS is associated with a two times increased risk for type 2 diabetes (T2D) [15].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [15]
Citations
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Self-citationHarris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107
Screening for type 2 diabetes.
Engelgau, M. M., Narayan, K. M. V., & Herman, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1563 · Cited by 1,026
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., POLSON, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 975
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
Manson, J. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060077013 · Cited by 675
Dunaif, A. E., GRAF, M., Mandeli, J., Laumas, V., & Dobrjansky, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 577
Cigarette smoking, relative weight, and menopause.
WILLETT, W., STAMPFER, M. J., BAIN, C., LIPNICK, R., SPEIZER, F. E., ROSNER, B., CRAMER, D., & HENNEKENS, C. H. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113598 · Cited by 558
Dunaif, A. E., & Finegood, D. T. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772555 · Cited by 457
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies
Hull, M. G. R. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709023610 · Cited by 423
Induction of insulin resistance by androgens and estrogens
Polderman, K. H., Gooren, L. J., Asscheman, H., Bakker, A., & Heine, R. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027240 · Cited by 382
The validity of recalled weight among younger women.
Troy, L. M., Hunter, D. J., Manson, J. E., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1995) · PubMed · Cited by 330
Insulin resistance, secretion, and metabolism in users of oral contraceptives
Godsland, I. F., Walton, C., Felton, C. V., Proudler, A. J., Patel, A., & Wynn, V. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.1.1530790 · Cited by 254
Haffner, S. M., Valdez, R. A., Morales, P. A., Hazuda, H. P., & D, M. P. S. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.8325960 · Cited by 178
The relationship of sex hormones to hyperinsulinemia and hyperglycemia
Haffner, S. M., Katz, M. S., Stern, M. P., & Dunn, J. F. (1988) · Metabolism · doi:10.1016/0026-0495(88)90091-1 · Cited by 140
Menstrual disorders in college students
Singh, K. B. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90277-5 · Cited by 93
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.1.s20 · Cited by 77
DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
Chang, R. J., & Katz, S. E. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70076-1 · Cited by 71
The Relationship of Menstrual Irregularity to Type 2 Diabetes in Pima Indian Women
Roumain, J., Charles, M.-A. A., de Courten, M., Hanson, R. L., Brodie, T. D., Pettitt, D. J., & Knowler, W. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.346 · Cited by 55
Weiss, D. J., Charles, M.-A. A., Dunaif, A. E., Prior, D. E., Lillioja, S., Knowler, W. C., & Herman, W. H. (1994) · Metabolism · doi:10.1016/0026-0495(94)90257-7 · Cited by 49
Polycystic ovary syndrome: Current and future treatment paradigms
Legro, R. S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70240-6 · Cited by 47
Streets, P. (2001) · BMJ · doi:10.1136/bmj.323.7310.453a · Cited by 40
Chasan‐Taber, L., Willett, W. C., Stampfer, M. J., Hunter, D. J., Colditz, G. A., Spiegelman, D. L., & Manson, J. E. (1997) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · Cited by 2
Hosmer (1997) · doi:10.1002/(sici)1097-0258(19970515)16:9
Cited by
Sorted by citations
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
“4% rate of physician-diagnosed hirsutism reported by the participants of the Nurses’ Health Study II (19).”
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“9% reported by 101,073 women participating in the Nurses’ Health Study II for cycles R32 days in length (57).”
BackgroundFauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Metadata
- Authors
- Solomon, C. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Solomon, Caren G.
- ORCID
- Solomon, Caren G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-21
- Volume
- 286
- Issue
- 19
- Pages
- 2421
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2043815784
- Cited by
- 362
- References
- 31
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 25 · 2021: 23 · 2020: 12 · 2019: 6 · 2018: 15 · 2017: 15 · 2016: 13 · 2015: 14 · 2014: 9 · 2013: 15 · 2012: 23
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA50385, R01CA050385)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- type 2 diabetes, menstrual cycle length, oligomenorrhea, menstrual irregularity, diabetes risk, obesity, insulin resistance, impaired glucose tolerance, women's health, Nurses' Health Study II
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Menstrual Cycle, Obesity, Oligomenorrhea, Prospective Studies, Regression Analysis, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review